Literature DB >> 1625445

Sequential assay of human milk immunoglobulins shows a predominance of lambda chains.

C M Molé1, P M Montagne, M C Béné, G C Faure.   

Abstract

BACKGROUND: Little is known of the light chains associated to heavy chains in secretions immunoglobulins. We investigated the partition of light chains in a mucosal fluid of easy access and major physiologic importance: human milk. EXPERIMENTAL
DESIGN: This study provides a sequential analysis of IgA, lambda and kappa chains levels in human milk during the first days of lactation. The levels of IgA alpha-chain and of lambda and kappa light chains of immunoglobulins were assayed in 162 samples of normal human milk collected during the first night of lactation, using a classical immunonephelometric assay. A specific enzyme-linked immunosorbent assay was developed to specifically measure the levels of IgA-linked light chains, yielding similar values. Ten samples of normal human serum obtained from healthy adults were tested in parallel.
RESULTS: The highest levels were observed during the first 3 days of lactation, and a plateau appeared for the three proteins after day 4. Mean lambda chains levels were consistently higher than these of kappa chains, resulting in a reversed kappa/lambda ratio, significantly different from the classical 2:1 serum ratio confirmed with this method on control samples.
CONCLUSIONS: This study indicates that milk immunoglobulins use an unusual partition of light chains, especially in IgA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1625445

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  2 in total

1.  Increases of IgA milk concentrations correlate with IgA2 increment.

Authors:  V Trégoat; P Montagne; M C Béné; G Faure
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

Review 2.  Antibodies in milk.

Authors:  E Telemo; L A Hanson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.